{"DataElement":{"publicId":"3922931","version":"1","preferredName":"Palifermin Planned Occurrence Or Administered Therapeutic Procedure Indicator","preferredDefinition":"Information related to whether palifermin was planned to be used or administered.","longName":"3922913v1.0:2677817v1.1","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3922913","version":"1","preferredName":"Palifermin Planned Occurrence Or Administered","preferredDefinition":"A recombinant form of the endogenous human keratinocyte growth factor with cell growth promoting activity. Palifermin acts in the manner similar to the endogenous keratinocyte growth factor that binds to keratinocyte growth factor receptors on the epithelial cell surface in the lining of mouth and gastrointestinal tract. This results in stimulation of epithelial cell proliferation, differentiation and upregulation of cytoprotective mechanisms._An instance of an event or incident that is intended to take place._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._The act of having given something (e.g., a medication or test).","longName":"2681991v1.0:3922911v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2681991","version":"1","preferredName":"Palifermin","preferredDefinition":"A recombinant form of the endogenous human keratinocyte growth factor with cell growth promoting activity. Palifermin acts in the manner similar to the endogenous keratinocyte growth factor that binds to keratinocyte growth factor receptors on the epithelial cell surface in the lining of mouth and gastrointestinal tract. This results in stimulation of epithelial cell proliferation, differentiation and upregulation of cytoprotective mechanisms.","longName":"C2455","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Palifermin","conceptCode":"C2455","definition":"A recombinant form of the endogenous human keratinocyte growth factor with cell growth promoting activity. Palifermin acts in the manner similar to the endogenous keratinocyte growth factor that binds to keratinocyte growth factor receptors on the epithelial cell surface in the lining of mouth and gastrointestinal tract. This results in stimulation of epithelial cell proliferation, differentiation and upregulation of cytoprotective mechanisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A1A47E2-6DE0-56AB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-14","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-14","modifiedBy":"ONEDATA","dateModified":"2007-09-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3922911","version":"1","preferredName":"Planned Occurrence Or Administered","preferredDefinition":"An instance of an event or incident that is intended to take place.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:The act of having given something (e.g., a medication or test).","longName":"C102557:C37998:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Planned Occurrence","conceptCode":"C102557","definition":"An instance of an event or incident that is intended to take place.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8F30331-8719-3508-E040-BB89AD433325","latestVersionIndicator":"Yes","beginDate":"2013-10-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-17","modifiedBy":"ONEDATA","dateModified":"2013-10-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8F30331-872A-3508-E040-BB89AD433325","latestVersionIndicator":"Yes","beginDate":"2013-10-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2677817","version":"1.1","preferredName":"Therapeutic Procedure Indicator","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether or not certain stated circumstances exist or criteria are satisfied.","longName":"THER_IND","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No: C49487","ValueMeaning":{"publicId":"2577728","version":"1","preferredName":"No: C49487","longName":"2577728","preferredDefinition":"The non-affirmative response to a question.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FCAD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-17","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-17","modifiedBy":"REEVESD","dateModified":"2006-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580921B0-775D-4402-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-29","modifiedBy":"ONEDATA","dateModified":"2008-09-29","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580921B0-7771-4402-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-29","modifiedBy":"ONEDATA","dateModified":"2008-09-29","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"2567168","version":"1","preferredName":"Yes","longName":"2567168","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":"12/29/2006 - Updated with NCI Thesaurus definition.","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580921B0-777B-4402-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-29","modifiedBy":"ONEDATA","dateModified":"2008-09-29","deletedIndicator":"No"},{"value":"Masked trial","valueDescription":"Blinded Clinical Study","ValueMeaning":{"publicId":"2789519","version":"1","preferredName":"Blinded Clinical Study","longName":"2789519","preferredDefinition":"A clinical study that is designed using a procedure in which one or more parties to the study [subject(s), investigator(s), monitor, or/and data analyst(s)] are kept unaware of the treatment assignment(s).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blinded Clinical Study","conceptCode":"C70840","definition":"A clinical study that is designed using a procedure in which one or more parties to the study [subject(s), investigator(s), monitor, or/and data analyst(s)] are kept unaware of the treatment assignment(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"580921B0-77A0-4402-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580921B0-77B9-4402-E044-0003BA3F9857","beginDate":"2008-09-29","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-29","modifiedBy":"ALEYR","dateModified":"2008-09-29","deletedIndicator":"No"},{"value":"Clinical trial","valueDescription":"Clinical Trial","ValueMeaning":{"publicId":"2677818","version":"1","preferredName":"Clinical Trial","longName":"2677818","preferredDefinition":"A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical study.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial","conceptCode":"C15207","definition":"A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3969F82A-869D-2904-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580921B0-77CE-4402-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-29","modifiedBy":"ALEYR","dateModified":"2008-09-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2684697","version":"1","preferredName":"Therapeutic Procedure Indicator","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.:An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"C49236:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AFC3669-5350-24B8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-25","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-09-25","modifiedBy":"ONEDATA","dateModified":"2007-09-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"580921B0-7745-4402-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-29","modifiedBy":"MAESKEB","dateModified":"2011-11-11","changeDescription":"09-29-08: Changed the value meaning of the permissible \"masked trial\" to \"blinded clinical study\" (C70840 ). Increased the max length to 60. Deleted the minimum length - RA","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PreTed_oth_tox_reg_palifermin_ynmask","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedObservationResult:value","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Was palifermin planned to use","type":"Preferred Question Text","description":"Was palifermin planned to use or administered?","url":null,"context":"NHLBI"},{"name":"Was KGF (palifermin, Kepivance) started or is there a plan to use it?","type":"Application Standard Question Text","description":"Was KGF (palifermin, Kepivance) started or is there a plan to use it?","url":null,"context":"NHLBI"},{"name":"BRIDG Mapping for CDE:3922931","type":"BRIDG Mapping Path","description":"PerformedObservationResult.value(ANY=>BL) WHERE PerformedObservationResult > PerformedObservation > DefinedObservation.nameCode = \"Start Administration or Plan KGF\" AND DefinedObservation > DefinedSubstanceAdministration [focal context #1] > Drug > MaterialName.name = \"Palifermin\" AND DefinedObservation > DefinedSubstanceAdministration [focal context #2] > Drug > MaterialName.name = \"Kepivance\"","url":null,"context":"NHLBI"},{"name":"Was KGF started or is there a plan to use it?","type":"Alternate Question Text","description":"Was KGF started or is there a plan to use it?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8F30331-8740-3508-E040-BB89AD433325","latestVersionIndicator":"Yes","beginDate":"2013-10-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-17","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":".1/15/14mn-added BRIDG info. Added human readable def. System generated def displayed as alt def. No version needed. AK 10/13/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}